Verastem (VSTM) Cash from Operations (2011 - 2026)
Verastem (VSTM) recorded quarterly Cash from Operations of 52116000.0 in Q1 2026, down 73.99% quarter-over-quarter from 29954000.0 in Q4 2025, and down 34.75% on a YoY basis from 79871549.22 in Q1 2025.
Verastem (VSTM) Cash from Operations (2011 - 2026) Analysis & Trends
Verastem's Cash from Operations history runs 16 years deep, the most recent figure standing at 52116000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 34.75% year-over-year to 52116000.0; the TTM figure through Mar 2026 stood at 150949000.0 (down 31.1% YoY), while the FY2025 annual figure was 137509000.0, down 31.25% from the prior year.
- Cash from Operations was 52116000.0 for Q1 2026 at Verastem, down from 29954000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 12694000.0 in Q2 2022 to a low of 52116000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26148764.71 across 5 years, with a median of 25099000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 78.63% in 2023, then advanced 15.44% in 2024.
- A 5-year view of Cash from Operations shows it stood at 16616000.0 in 2022, then tumbled by 78.63% to 29681000.0 in 2023, then rose by 15.44% to 25099000.0 in 2024, then declined by 19.34% to 29954000.0 in 2025, then sank by 73.99% to 52116000.0 in 2026.
- The last three Cash from Operations figures came in at 52116000.0 (Q1 2026), 29954000.0 (Q4 2025), and 36216000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -52.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.12 Mn |
| Mar 31, 2026 | -52.12 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Jun 30, 2024 | -27.57 Mn |
| Jun 30, 2024 | -27.57 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Dec 31, 2023 | -29.68 Mn |
| Dec 31, 2023 | -29.68 Mn |